(SRRA) – Management Comments
-
Codexis (CDXS) Announces CEO Transition Effective August 9
-
Sierra Oncology (SRRA) Presents Favorable Long-Term Safety and Dose Intensity Data for Momelotinib at EHA25 2020 Virtual Meetings
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SRRA Stock Lookup